Related Experiment Video
Updated: Aug 14, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
[Carcinogen activity of the new drug thymodepressin studied in chronic tests on rats and mice]
Abstract:
The new drug thymodepressin was subcutaneously injected in doses 0.0145 and 0.145 mg/kg in rats and mice over a period of 104 weeks. No statistically significant difference in the tumor frequencies between the test and control groups was observed during this period of time. It is concluded that thymodepressin is not carcinogenic.
More Related Videos
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
04:14In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
Published on: October 6, 2023
Related Concept Videos
Mutagenicity and Carcinogenicity
Toxicity Testing in Animals